These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Strategic considerations for the biotechnology business to the year 2000. Cometta S Arzneimittelforschung; 1989 Aug; 39(8):929-34. PubMed ID: 2818683 [TBL] [Abstract][Full Text] [Related]
27. Outcomes research: priorities for an evolving field. Stryer DB; Siegel JE; Rodgers AB Med Care; 2004 Apr; 42(4 Suppl):III1-5. PubMed ID: 15026671 [No Abstract] [Full Text] [Related]
29. Bioremediation: environmental clean-up through pathway engineering. Singh S; Kang SH; Mulchandani A; Chen W Curr Opin Biotechnol; 2008 Oct; 19(5):437-44. PubMed ID: 18760355 [TBL] [Abstract][Full Text] [Related]
30. Underwhelmed: hyperbole, regulatory policy, and the genetic revolution. Caulfield T McGill Law J; 2000 May; 45(2):437-60. PubMed ID: 12688281 [TBL] [Abstract][Full Text] [Related]
31. These 3 profound changes are shaping the future of medical care. Hoff LC Pharm Times; 1983 Jan; 49(1):19-23. PubMed ID: 10289375 [No Abstract] [Full Text] [Related]
32. Is a paradigm shift in US healthcare reimbursement inevitable? Watanabe AM; Dollens RW; Malatestinic WN; Browne RA Circulation; 2004 Mar; 109(12):1456-9. PubMed ID: 15051649 [No Abstract] [Full Text] [Related]
33. Biotechnology and the creation of ethics. Coletta RR McGeorge Law Rev; 2000; 32(1):89-110. PubMed ID: 16523579 [No Abstract] [Full Text] [Related]
34. A high-level view of health care. Mathias JM OR Manager; 2003 Jan; 19(1):16-7. PubMed ID: 12555719 [No Abstract] [Full Text] [Related]
35. What is digital medicine? Shaffer DW; Kigin CM; Kaput JJ; Gazelle GS Stud Health Technol Inform; 2002; 80():195-204. PubMed ID: 12026129 [TBL] [Abstract][Full Text] [Related]
36. Molecular medicine and information-based targeted healthcare. Poste G Nat Biotechnol; 1998 May; 16 Suppl():19-21. PubMed ID: 9591257 [No Abstract] [Full Text] [Related]
37. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice. Piascik P Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234 [TBL] [Abstract][Full Text] [Related]
38. [At the beginning of the third millennium: what kind of surgery, what kind of surgeon?]. Serio G Chir Ital; 2000; 52(1):1-9. PubMed ID: 10832521 [TBL] [Abstract][Full Text] [Related]
39. Is a paradigm shift in US healthcare reimbursement inevitable? Weintraub WS; Shine K Circulation; 2004 Mar; 109(12):1448-55. PubMed ID: 15051648 [No Abstract] [Full Text] [Related]
40. Perspectives: parity--prelude to a fifth cycle of reform. Goldman HH J Ment Health Policy Econ; 2002 Sep; 5(3):109-13. PubMed ID: 12728197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]